| Serial Number | 97690153 |
| Word Mark | SURMOUNT BIO |
| Filing Date | Wednesday, November 23, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Thursday, October 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| NOT AVAILABLE | "BIO" |
| Goods and Services | Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 28, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | elevatebio, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Party Name | elevatebio, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Saturday, November 26, 2022 | NEW APPLICATION ENTERED |
| Monday, November 28, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 16, 2023 | ASSIGNED TO EXAMINER |
| Monday, September 11, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 11, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 11, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 11, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 11, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, June 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 7, 2024 | SOU EXTENSION 1 FILED |
| Friday, June 7, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, November 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 19, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, November 19, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, November 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 16, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, October 16, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |